$RVXCF watch for news of financing... Biggest r
Post# of 98045
Biggest risk imo is a lack of funds to deliver on what I see as multi-billion dollar potential for Phase III drug candidate Apabetalone. I don't think they'll have any trouble raising the money needed to advance toward full approval if their trial succeeds, but right now it is an uncertainty....expecting a pop with news of funding.